Scarica l'app Stockscreener
6.60
1.49%
-0.10
Dopo l'orario di chiusura:
6.55
-0.05
-0.76%
Precedente Chiudi:
$6.70
Aprire:
$6.82
Volume 24 ore:
11,696
Relative Volume:
0.64
Capitalizzazione di mercato:
$31.03M
Reddito:
$5.75M
Utile/perdita netta:
$-38.72M
Rapporto P/E:
-94.29
EPS:
-0.07
Flusso di cassa netto:
$-31.04M
1 W Prestazione:
-10.81%
1M Prestazione:
+26.92%
6M Prestazione:
+0.76%
1 anno Prestazione:
+21.10%
Intervallo 1D:
$6.45
$6.82
Intervallo di 1 settimana:
$6.45
$7.50
Portata 52W:
$4.21
$10.97
Kala Bio Inc Stock (KALA) Company Profile
Nome
Kala Bio Inc
Settore
Industria
Telefono
781-996-5252
Indirizzo
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Confronta KALA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| KALA | 6.60 | 31.03M | 5.75M | -38.72M | -31.04M | -0.07 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-03-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-07-23 | Iniziato | Northland Capital | Outperform |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2020-05-27 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Kala Bio Inc Borsa (KALA) Ultime notizie
ADAR1 Capital Management, LLC Increases Stake in Kala Bio Inc - GuruFocus.com
KALA BIO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
KALA BIO: Q3 Earnings Snapshot - mySA
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
KALA BIO Reports $49.2M Cash Position, Advances Phase 2b PCED Trial Despite Wider Losses | KALA Stock News - StockTitan
Super Micro slumps as weak forecast, annual report uncertainty fuel investor angst - AOL
Standard Life Private Equity Trust (LON:SLPE) Trading Down 1.5% – Here’s Why - Defense World
Travis Kalanick | Biography, Uber, & Facts - Britannica
Persistent Corneal Epithelial Defects Pipeline 2024: Clinical - openPR
Persistent Epithelial Defect Market Size is Set for Rapid Growth - openPR
Sunrun (NASDAQ:RUN) Trading Down 5.8% on Insider Selling - Defense World
MPTI Stock Trades Near 52-Week High: Is It Still Worth Buying? - MSN
Here's What Makes Cabot Stock a Solid Choice Right Now - MSN
Here's Why Welltower Stock is an Apt Portfolio Pick for Now - MSN
Broadcom Stock Hits Buy Point On Product News Ahead Of Major Conference - MSN
KALA BIO (KALA) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
Dynatrace Shows Improved Relative Strength; Still Shy Of Benchmark - MSN
Brookdale Bets Big With $610M Acquisitions Amid Debt Refinancing - MSN
Toast, Inc. (TOST) is Attracting Investor Attention: Here is What You Should Know - MSN
Here's Why Freeport-McMoRan Stock Soared in September - AOL
Oppenheimer Initiates Coverage of Euronet Worldwide (EEFT) with Outperform Recommendation - MSN
Transparency-One’s Kala Hanson Named Recipient of 2024 Women in Supply Chain Award - Yahoo Finance
KALA BIO director resigns from board and committees By Investing.com - Investing.com Australia
KALA BIO director resigns from board and committees - Investing.com
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns - TipRanks
Kaival Brands’ (KAVL) Stock Surges After Merger Announcement with Delta Corp. - TipRanks
(KALA) Long Term Investment Analysis - Stock Traders Daily
Glazer Capital LLC Trims Holdings in Kairous Acquisition Corp. Limited (NASDAQ:KACL) - Defense World
Kaival Brands Innovations Group Inc. (NASDAQ:KAVL) Stock Makes a Big Move: But Why? - DRP Journal
Celebrities pour in appreciation for Vikky Varun's Kalapatthar - Cinema Express
Luminar Technologies Surged Today on Potential Trade Protections - AOL
Market Movers Monday: KAVL, PRSO, TGL, PNPNF, NVVE Surge on Breaking Developments - openPR
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO), Kaival Brands (NASDAQ: KAVL) among others w/Key Announcements - Barchart
Kaival Brands Shares More Than Double on Delta Corp Holdings Merger - MarketWatch
What's Going On With Kaival Brands Stock Monday? - Benzinga
Kaival Brands Announces Strategic Merger with Delta Corp - TipRanks
Delta Corp Holdings Limited, a Fast Growing Asset-Light Logistics Company Enters into a Definitive Merger and Share Exchange Agreement with Kaival Brands Innovations Group, Inc. - StockTitan
Kayne Anderson Rudnick Investment Management LLC Purchases 15,512 Shares of Kadant Inc. (NYSE:KAI) - Defense World
ProShares Short S&P500 (NYSEARCA:SH) Hits New 12-Month Low at $11.02 - Defense World
Orange (NYSE:ORAN) Trading Down 1.7% - Defense World
Mutual of America Capital Management LLC Has $5.55 Million Stock Holdings in Rexford Industrial Realty, Inc. (NYSE:REXR) - Defense World
Mutual of America Capital Management LLC Reduces Holdings in Occidental Petroleum Co. (NYSE:OXY) - Defense World
Mutual of America Capital Management LLC Boosts Position in Electronic Arts Inc. (NASDAQ:EA) - Defense World
Rhumbline Advisers Raises Position in Reynolds Consumer Products Inc. (NASDAQ:REYN) - Defense World
Sensei Biotherapeutics names new financial chief - Investing.com India
Sensei Biotherapeutics names new financial chief By Investing.com - Investing.com South Africa
Stocks stutter, dollar sags; Nvidia earnings in focus - AOL
KALA BIO (KALA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
KALA BIO (NASDAQ:KALA) Given “Outperform” Rating at Oppenheimer - Defense World
KALA (Kala Bio) Shares Outstanding (EOP) : 4.60 Mil (As of Jun. 2024) - GuruFocus.com
Financial Review: Lipella Pharmaceuticals (NASDAQ:LIPO) vs. Sagimet Biosciences (NASDAQ:SGMT) - Defense World
Kala Bio Inc Azioni (KALA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):